This blog is where we share stories, announcements, and insights from around the iGEM community.
All in iGEM Innovation
iGEM Innovation aims to support bioinnovators to turn their innovations into lasting impact. Through the Venture Creation Lab (VCL), early-stage teams are introduced to the practical foundations of building a synthetic biology venture from a research background, covering everything from customer discovery to commercialisation.
Carolina Villa spent a decade scaling bioprocesses in industry: first at DSM, the Dutch multinational known for its fermentation and biotechnology work, then at CJ CheilJedang, a South Korean food and biotechnology company and one of the world's largest producers of fermentation-based bioproducts. She has since moved to the investor side, where she's now a Principal at Nucleus Capital, supporting pre-seed to early-stage deeptech climate startups.
Meet Pedro Lovatt Garcia, Co-Founder and CTO of tera, previously known as Anzen Industries, a cell-free biomanufacturing startup that recently closed its £2.2M pre-seed funding round from leading European venture capital (VC) firms. This fundraise marks a significant milestone for tera as it prepares for its next phase of growth in the United States.
